These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6739505)

  • 1. Dissolution studies of some regular and sustained-release dyphylline dosage forms.
    Simons KJ; Plett KD; Simons FE
    Pharm Acta Helv; 1984; 59(5-6):145-8. PubMed ID: 6739505
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro study of dissolution rate of diphylline tablets.
    Rekkas DM; Papaioannou G
    Pharm Acta Helv; 1986; 61(5-6):164-6. PubMed ID: 3725817
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissolution assay of theophylline, diprophylline and proxyphylline from a sustained release dosage form by high performance thin layer chromatography.
    Agbaba D; Zivanov-Stakić D; Vukićević N
    Biomed Chromatogr; 1992; 6(3):141-2. PubMed ID: 1525489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of a sustained-release dyphylline formulation.
    Simons KJ; Simons FE; Bierman CW
    J Clin Pharmacol; 1977 Apr; 17(4):237-41. PubMed ID: 849997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two dissolution apparatuses: rotating basket versus rotating flask.
    Koch HP; Alcorn G; Ritschel WA
    Pharmazie; 1983 Apr; 38(4):233-5. PubMed ID: 6867085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro dissolution behavior of some sustained-release theophylline dosage forms.
    Lin SY; Yang JC
    Pharm Acta Helv; 1989; 64(8):236-40. PubMed ID: 2780758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of second derivative spectrometry to the determination of bromhexine hydrochloride and spectrophotometry to the determination of dyphylline in compound preparations].
    Tang SR
    Yao Xue Xue Bao; 1986 Oct; 21(10):776-80. PubMed ID: 3577779
    [No Abstract]   [Full Text] [Related]  

  • 8. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of three dyphylline preparations.
    Stablein JJ; Samaan SS; Bukantz SC; Lockey RF
    Eur J Clin Pharmacol; 1983; 25(2):281-3. PubMed ID: 6628514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans.
    Straughn AB; Wood GC; Raghow G; Meyer MC
    J Pharm Sci; 1985 Mar; 74(3):335-7. PubMed ID: 4009445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of potential prodrugs of dyphylline.
    Ayres JW; Panomvana D; Block JH
    J Pharm Sci; 1985 Feb; 74(2):184-7. PubMed ID: 3989689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
    Goole J; Vanderbist F; Amighi K
    Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline].
    Laicher A; Fuchs WS
    Arzneimittelforschung; 1998 May; 48(5A):540-7. PubMed ID: 9676341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of dyphylline in humans.
    Simons KJ; Simons FE
    J Pharm Sci; 1979 Oct; 68(10):1327-9. PubMed ID: 512873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical challenges in the development of modified-release oral solid dosage forms. A review.
    Bowker MJ
    Analyst; 1996 Oct; 121(10):91R-100R. PubMed ID: 8918212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.